Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84K Buy
711
+138
+24% +$15.9K 0.01% 430
2026
Q1
$68.5K Buy
573
+2
+0.4% +$262 0.01% 480
2025
Q4
$77.8K Sell
571
-13
-2% -$1.87K 0.01% 461
2025
Q3
$86.1K Sell
584
-6
-1% -$832 0.01% 473
2025
Q2
$76.3K Sell
590
-1
-0.2% -$121 0.01% 479
2025
Q1
$70.6K Sell
591
-31
-5% -$3.84K 0.01% 479
2024
Q4
$72.2K Sell
622
-797
-56% -$101K 0.01% 502
2024
Q3
$192K Buy
1,419
+892
+169% +$119K 0.03% 313
2024
Q2
$71.5K Buy
527
+2
+0.4% +$272 0.01% 461
2024
Q1
$67.9K Hold
525
0.01% 474
2023
Q4
$60K Hold
525
0.01% 476
2023
Q3
$47.8K Sell
525
-1
-0.2% -$103 0.01% 483
2023
Q2
$59.2K Sell
526
-12
-2% -$1.27K 0.01% 454
2023
Q1
$56.3K Hold
538
0.01% 446
2022
Q4
$59.5K Buy
+538
New +$56.4K 0.02% 412

Other funds holding XYL

Colonial Trust's XYL Position: Q2 2026 in Review

Colonial Trust increased its Xylem (XYL) stake by 24% in Q2 2026, buying an estimated $15.9K and bringing the position to 711 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #430.

Colonial Trust first reported a position in XYL in Q4 2022 and has held it in 15 quarters since. The position peaked at $192K in Q3 2024. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Colonial Trust held 711 shares of Xylem worth $84K as of Q2 2026.
  • Colonial Trust bought 138 Xylem shares in Q2 2026, an estimated $15.9K.
  • Xylem made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #430 holding.
  • Colonial Trust first reported a position in Xylem in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust's Xylem position peaked at $192K in Q3 2024.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.